UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) Delaware 86-3988281 (State or other juri ...

Definitive Healthcare Corp. (NASDAQ:DH) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants David Samuels - General Counsel & Chief Legal Officer Jason Krantz - Founder and CEO Robert Musslewhite - President Richard Booth - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley David Hynes - Canaccord Genuity Jonathan Yong - Credit Suisse David Grossman - Stifel Operator Greetings, and welcome to Definitive Healthcare First Quarter 2022 Earnings Con ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) Delaware 86-3988281 (State or other jur ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40815 Definitive Healthcare Corp. (Exact name of Registrant as specified in its Charter) Delaware 86-3988281 (State or other jurisdic ...

Definitive Healthcare Corp. (NASDAQ:DH) Q4 2021 Earnings Conference Call February 23, 2022 5:00 PM ET Company Participants David Samuels - General Counsel & Chief Legal Officer Jason Krantz - Founder and CEO Rick Booth - Chief Financial Officer Robert Musslewhite - President Conference Call Participants Craig Hettenbach - Morgan Stanley Kash Rangan - Goldman Sachs Saket Kalia - Barclays Adam Watts - Credit Suisse Brian Peterson - Raymond James David Grossman - Stifel Glen Santangelo - Jefferies Operator Gre ...

Definitive Healthcare Corp. (NASDAQ:DH) Q3 2021 Earnings Conference Call November 8, 2021 5:00 PM ET Company Participants Brian Denyeau - ICR, IR Jason Krantz - Founder and CEO Rick Booth - Chief Financial Officer Conference Call Participants Sterling Auty - JP Morgan Craig Hettenbach - Morgan Stanley Saket Kalia - Barclays Kash Rangan - Goldman Sachs Adam Watts - Credit Suisse George Hill - Deutsche Bank DJ Hynes - Canaccord Brian Peterson - Raymond James David Grossman - Stifel Operator Greetings. And wel ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Securities registered pursuant to Section 12(b) of the Act: | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------------------------------------------------- ...